LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition

por Mahoney, C L, Choudhury, B, Davies, H, Edkins, S, Greenman, C, Haaften, G van, Mironenko, T, Santarius, T, Stevens, C, Stratton, M R, Futreal, P A
Publicado 2009